To access this element change to forms mode OFF
Grant Award View - GA56980
Better Treatments For Breathlessness In Palliative And End Of Life Care
GA ID:
GA56980
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
14-Jan-2019
Publish Date:
6-Aug-2019
Category:
Medical Research
Grant Term:
1-Jun-2019 to 31-May-2023
Value (AUD):
$499,430.90
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 18/19 1.1 Health and Medical Research
Grant Program:
European Union
Grant Activity:
Better Treatments For Breathlessness In Palliative And End Of Life Care
Purpose:
People with emphysema or lung scarring frequently have breathlessness at rest, dressing, showering or preparing meals, despite best treatment for the disease. Globally, no medication is approved for this breathlessness. This 6 country study will test mirtazapine, a medication usually used in depression, reducing breathlessness even if people are not depressed. This study will give mirtazapine or a sugar tablet (on a coin toss) for 8 weeks to measure benefits and harms on worst breathlessness.
GO ID:
GO Title:
National Health and Medical Research Council-European Union Collaborative Research Grants scheme funding in 2019
Internal Reference ID:
GNT1170731
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Technology Sydney
Recipient ABN:
77 257 686 961
Grant Recipient Location
Suburb:
Ultimo
Town/City:
Ultimo
Postcode:
2007
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, GERMANY, IRELAND, ITALY, POLAND, SWITZERLAND, UNITED KINGDOM